MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$278,406K
(-61.91%↓ Y/Y)
Unrealized gain on
short-term investments
$260K
Net loss
-$278,666K
(-60.17%↓ Y/Y)
Interest and other
income, net
$26,774K
(17.18%↑ Y/Y)
Loss before income
taxes
-$278,369K
(-61.88%↓ Y/Y)
Income tax expense
$297K
(-85.28%↓ Y/Y)
Total other income,
net
$25,262K
(18.99%↑ Y/Y)
License And
Collaboration Revenue
$65,350K
Product
$2,132K
Interest expense
$1,512K
(-6.61%↓ Y/Y)
Loss from operations
-$303,631K
(-57.16%↓ Y/Y)
Total revenue
$67,482K
(25.24%↑ Y/Y)
Total operating
expenses
$371,113K
(50.20%↑ Y/Y)
Research and development
$251,074K
(47.72%↑ Y/Y)
Selling, general and
administrative
$119,982K
Cost of product sales
$57K
Back
Back
Income Statement
source: myfinsight.com
Kura Oncology, Inc. (KURA)
Kura Oncology, Inc. (KURA)